A New Laminin a2-Based Gene Therapy for Congenital Muscular Dystrophy 1A

被引：0
|
作者：
Packer, Davin [1 ,2 ]
Martin, Paul T. [1 ,3 ]
机构：
[1] Nationwide Childrens Hosp, Ctr Gene Therapy, Columbus, OH USA
[2] Ohio State Univ, Neurosci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med, Dept Pediat, Columbus, OH 43210 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
498
引用
收藏
页码：219 / 219
页数：1
相关论文
共 50 条
  • [21] Cellular rescue in a zebrafish model of congenital muscular dystrophy type 1A
    T. E. Hall
    A. J. Wood
    O. Ehrlich
    M. Li
    C. S. Sonntag
    N. J. Cole
    I. G. Huttner
    T. E. Sztal
    P. D. Currie
    npj Regenerative Medicine, 4
  • [22] RNAi Therapy for Limb Girdle Muscular Dystrophy Type 1A
    Liu, Jian
    Wallace, Lindsay
    Garwick-Coppens, Sara
    Davis, Carol
    Hakim, Chady
    Guckes, Susan
    Hauser, Michael
    Mendell, Jerry
    Brooks, Susan
    Harper, Scott
    MOLECULAR THERAPY, 2013, 21 : S112 - S113
  • [23] New advancements in CRISPR based gene therapy of Duchenne muscular dystrophy
    Eslahi, Atieh
    Alizadeh, Farzaneh
    Avan, Amir
    Ferns, Gordon A.
    Moghbeli, Meysam
    Abbaszadegan, Mohammad Reza
    Mojarrad, Majid
    GENE, 2023, 867
  • [24] Treatment approaches in laminin-α2-deficient congenital muscular dystrophy (MDC1A)
    Meinen, S.
    Lin, S.
    Rueegg, M. A.
    NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 550 - 550
  • [25] Laminin alpha 2 chain-null mutant mice by targeted disruption of the Lama2gene: a new model of merosin (laminin 2)-deficient congenital muscular dystrophy
    Miyagoe, Y
    Hanaoka, K
    Nonaka, I
    Hayasaka, M
    Nabeshima, Y
    Arahata, K
    Nabeshima, Y
    Takeda, S
    FEBS LETTERS, 1997, 415 (01) : 33 - 39
  • [26] Laminin α1 chain reduces muscular dystrophy in laminin α2 chain deficient mice
    Gawlik, K
    Miyagoe-Suzuki, Y
    Ekblom, P
    Takeda, S
    Durbeej, M
    HUMAN MOLECULAR GENETICS, 2004, 13 (16) : 1775 - 1784
  • [27] ABNORMAL NEURONAL MIGRATION IDENTIFIED BY BRAIN PATHOLOGY IN CONGENITAL MUSCULAR DYSTROPHY 1A
    Jayakody, Himali
    Mathews, Katherine
    Moore, Steven
    MUSCLE & NERVE, 2016, 54 (03) : 534 - 534
  • [28] Autophagy increase in Merosin-Deficient Congenital Muscular Dystrophy type 1A
    Mastrapasqua, Mariangela
    Rossi, Roberta
    De Cosmo, Lucrezia
    Resta, Annalisa
    Errede, Mariella
    Bizzoca, Antonella
    Zampatti, Stefania
    Resta, Nicoletta
    Giardina, Emiliano
    Ruggieri, Maddalena
    Virgintino, Daniela
    Annese, Tiziana
    Laforgia, Nicola
    Girolamo, Francesco
    EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY, 2023, 33 (03)
  • [29] Do alterations in laminin beta 2 localisation indicate a role of laminin-4 in congenital muscular dystrophy?
    Jimenez-Mallebrera, C
    Feng, L
    Brown, SC
    Muntoni, F
    Sewry, CA
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 656 - 656
  • [30] Merosin-deficient congenital muscular dystrophy type 1A: A case report
    He, Zhanwen
    Luo, Xiangyang
    Liang, Liyang
    Li, Pinggan
    Li, Dongfang
    Zhe, Meng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2013, 6 (05) : 1233 - 1236
12345